-- Detailed overview of the clinical presentation and diagnosis of CD --
with video depictions demonstrating abnormal movements and which muscle
-- Review of currently available treatments -- oral medications, surgical
options, injections with botulinum toxin, and complementary therapies
-- Fundamentals for dosing and muscle injection techniques when using
MYOBLOC to reduce the severity of abnormal head position and neck pain
associated with CD
-- Patient case studies that illustrate the challenges and potential
solutions in managing CD patients
-- A post-test for participants to gauge their understanding of the
Upon completing the online lesson, physicians can request in-person training with MYOBLOC, which is available through Solstice in a variety of venues. The company's overall goal is to support physicians who care for CD patients -- ranging from neurologists to physiatrists to anesthesiologists and pain management physicians.
MYOBLOC(TM) University does not offer continuing medical education credits.
Myobloc(R) (Botulinum Toxin Type B) Injectable Solution is indicated for the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.
Before administering MYOBLOC, physicians should consult the full Prescribing Information.
The most frequently reported adverse events with MYOBLOC are dry mouth,
dysphagia, dyspepsia, and injection site pain. These adverse events are
|SOURCE Solstice Neurosciences, Inc.|
Copyright©2007 PR Newswire.
All rights reserved